BACKGROUND: Highly active antiretroviral therapy (HAART) has transformed human immunodeficiency virus infection (HIV) into a chronic condition. The effects of long-term HAART on the immune system activity of early infected children are not fully understood. Hence, the aim of this review is to investigate immune system recovery and residual alteration in HIV-infected children receiving HAART in high-income countries. METHODS: A systematic review was performed by searches of PubMed and references of the relevant articles. Studies published between January 1, 2000 and April 1, 2014 and conducted in high-income countries reporting data on immunological features in HIV-infected children receiving HAART were included in this review. RESULTS: Fifty-three articles were included in this review. Present knowledge on B-cell and T-cell function, immunoglobulin production, response to vaccine and innate immune system activity in HIV-infected children receiving HAART is discussed. CONCLUSION: Starting therapy as soon as diagnosis is ascertained and monitoring vaccine response in children under HAART are the most important tools to safeguard immunological function in HIV-infected children.
BACKGROUND: Highly active antiretroviral therapy (HAART) has transformed human immunodeficiency virus infection (HIV) into a chronic condition. The effects of long-term HAART on the immune system activity of early infected children are not fully understood. Hence, the aim of this review is to investigate immune system recovery and residual alteration in HIV-infectedchildren receiving HAART in high-income countries. METHODS: A systematic review was performed by searches of PubMed and references of the relevant articles. Studies published between January 1, 2000 and April 1, 2014 and conducted in high-income countries reporting data on immunological features in HIV-infectedchildren receiving HAART were included in this review. RESULTS: Fifty-three articles were included in this review. Present knowledge on B-cell and T-cell function, immunoglobulin production, response to vaccine and innate immune system activity in HIV-infectedchildren receiving HAART is discussed. CONCLUSION: Starting therapy as soon as diagnosis is ascertained and monitoring vaccine response in children under HAART are the most important tools to safeguard immunological function in HIV-infectedchildren.
Authors: Heather Haq; Peter Elyanu; Shaun Bulsara; Jason M Bacha; Liane R Campbell; Nader K El-Mallawany; Elizabeth M Keating; Grace P Kisitu; Parth S Mehta; Chris A Rees; Jeremy S Slone; Adeodata R Kekitiinwa; Mogomotsi Matshaba; Michael B Mizwa; Lumumba Mwita; Gordon E Schutze; Sebastian R Wanless; Michael E Scheurer; Joseph Lubega Journal: Cancers (Basel) Date: 2021-03-18 Impact factor: 6.639